Patent · US Active

Methods and systems for treating cell proliferation disorders with psoralen derivatives

US8383836B2 · kind B2 · utility

5Cited by
0References
9Claims
0Family size

Assignees

Inventors

Key dates

Filing dateApr 20, 2010
Grant dateFeb 26, 2013
Priority date—
Expiry dateMay 3, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Psoralen compounds of Formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.